HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michelle Taylor Selected Research

Opiate Overdose

1/2022Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michelle Taylor Research Topics

Disease

5Substance-Related Disorders (Drug Abuse)
01/2019 - 08/2007
2Neuroinflammatory Diseases
11/2021 - 01/2020
2Parkinson Disease (Parkinson's Disease)
05/2021 - 01/2021
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 01/2020
2Tobacco Use Disorder (Nicotine Dependence)
01/2020 - 01/2017
2Schizophrenia (Dementia Praecox)
01/2020 - 06/2011
1Opiate Overdose
01/2022
1Dyskinesias (Dyskinesia)
05/2021
1Inflammation (Inflammations)
01/2021
1COVID-19
10/2020
1Autistic Disorder (Autism)
01/2020
1Multiple Sclerosis
01/2020
1Opioid-Related Disorders (Opiate Addiction)
11/2018
1Antisocial Personality Disorder (Antisocial Personality)
12/2017
1Hemolytic Anemia
01/2016
1Thrombotic Thrombocytopenic Purpura
01/2016
1Thrombotic Microangiopathies
01/2016
1Movement Disorders (Movement Disorder)
01/2013
1Bipolar Disorder (Manic Depressive Psychosis)
06/2011
1Nervous System Diseases (Neurological Disorders)
03/2011
1Dystonia (Limb Dystonia)
01/2011
1Dystonic Disorders (Writer's Cramp)
01/2011
1Oligohydramnios
04/2007
1Birth Weight (Birth Weights)
04/2007
1Fetal Weight
04/2007
1Cocaine-Related Disorders (Cocaine Addiction)
02/2005

Drug/Important Bio-Agent (IBA)

6Dopamine Receptors (Dopamine Receptor)IBA
05/2021 - 01/2011
3LigandsIBA
05/2021 - 08/2007
2Illicit Drugs (Recreational Drugs)IBA
01/2017 - 01/2017
2Dopamine D3 ReceptorsIBA
08/2014 - 08/2007
1Naloxone (Narcan)FDA LinkGeneric
01/2022
1Complement C3 (C3 Complement)IBA
11/2021
1Levodopa (L Dopa)FDA LinkGeneric
05/2021
1Oxidopamine (6 Hydroxydopamine)IBA
05/2021
1ChemokinesIBA
01/2021
1Glucagon-Like Peptide-1 ReceptorIBA
01/2021
1Neuroprotective AgentsIBA
01/2021
1GTP-Binding Proteins (G-Protein)IBA
01/2020
1ursodoxicoltaurineIBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1Cocaine (Cocaine HCl)IBA
01/2020
1Heroin (Diamorphine)IBA
01/2020
1SmokeIBA
01/2020
1CalciumIBA
11/2018
1Biological ProductsIBA
12/2017
1thiamine triphosphorate (TTP)IBA
01/2016
11- ((5- methoxy- 1H- indol- 3- yl)methyl)- 4- (4- (methylthio)phenyl)piperidin- 4- olIBA
01/2013
1Antidepressive Agents (Antidepressants)IBA
06/2011
1Antipsychotic Agents (Antipsychotics)IBA
06/2011
1Aripiprazole (Abilify)FDA Link
06/2011
1SpiperoneIBA
01/2011
1pyridineIBA
08/2007
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA
08/2007
1cyclo(Arg-Pro) (CI 4)IBA
04/2007
1Pharmaceutical PreparationsIBA
02/2005

Therapy/Procedure

3Therapeutics
01/2019 - 08/2014
1Standing Orders
01/2022
1Continuity of Patient Care
10/2020
1Plasma Exchange
01/2016